Bandingkan Harga & Kinerja Pollux Properties Indonesia Tbk. (POLL) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Pollux Properties Indonesia Tbk. dan Organon Pharma Indonesia Tbk.: Pollux Properties Indonesia Tbk. diperdagangkan di Rp112 (kapitalisasi pasar 931,71 M), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Pollux Properties Indonesia Tbk. jauh lebih besar — sekitar 8,9× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| POLL | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 931,71 M | 104,4 M |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Pollux Properties Indonesia Tbk.
PT Pollux Properti Indonesia, Tbk (the "Company" or "Parent Company") established on Jakarta based on the Notarial Deed No. 40 dated December 16, 2014 by Ferdinandus Indra Santoso Atmajaya, S.H., M.H., as a substitute of Notary Esther Mercia Sulaiman, S.H., a notary in Jakarta.
Selengkapnya di halaman POLL →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
